| Affiliation: | Julie L. Gerberding, M.D., M.P.H., is Director, Centers for Disease Control and Prevention, and Administrator, Agency for Toxic Substances and Disease Registry. Earlier she was Acting Deputy Director of the National Center for Infectious Diseases where she played a major role in leading CDC's response to the anthrax bioterrorism events of 2002.;Anthony D. Moulton, Ph.D., is Director of Programs, Public Health Law Program, Centers for Disease Control and Prevention. Earlier he served as Acting Deputy Director, Public Health Practice Program Office, CDC, and as Deputy Commissioner for Budget and Planning, Office of the Governor, Missouri.;Richard A. Goodman, M.D., J.D., M.P.H., is Director for Science and Law, Public Health Law Program, CDC. His degrees are froni the University of Michigan, Ann Arbor (M.D.), Emory University, Atlanta J.D.) and tlie University of California, Los Angeles (M.P.H.);Montrece McNeill Ransom, J.D., is an Attorney-Analyst with the Public Health Law Program, CDC. Ms. Ransom has served as a Presidential Management Intern at CDC in the Financial Management Office and with the DeKalb County (Georgia) Board of Health. |
